%0 Journal Article
%T Randomized, double©\blind, placebo©\controlled study of interferon©\¦Ã 1b in Friedreich Ataxia
%A Alicia Brocht
%A Amy Grahn
%A Ashley McCormick
%A Jeffrey W. Sherman
%A Jennifer M. Farmer
%A Julie Ball
%A Katherine D. Mathews
%A Kim Schadt
%A Lauren Hauser
%A McKenzie Wells
%A Renee Perdok
%A Shana McCormack
%A Sub H. Subramony
%A Susan Perlman
%A Tom Vescio
%A Yi Na Dong
%J Archive of "Annals of Clinical and Translational Neurology".
%D 2019
%R 10.1002/acn3.731
%X In vitro, in vivo, and open©\label studies suggest that interferon gamma (IFN©\¦Ã 1b) may improve clinical features in Friedreich Ataxia through an increase in frataxin levels. The present study evaluates the efficacy and safety of IFN©\¦Ã 1b in the treatment of Friedreich Ataxia through a double©\blind, multicenter, placebo©\controlled trial
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414489/